Back to search
Bioavailability and Pharmacokinetics
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Bioavailability and Pharmacokinetics trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Bioavailability and Pharmacokinetics trials you may qualify forThe purpose of this study is to evaluate the relative bioavailability (rBA) of the Form 2 film-coated tablet of PF-07799933 intended for use in future studies c…
This is a Phase 1, randomized, single-dose, open-label, two-way crossover study to evaluate the effect of food on AJ201, and to evaluate the safety, tolerabilit…
The purpose of this study is to assess how well laroprovstat and rosuvastatin combined in a single tablet to be taken by mouth works compared with laroprovstat…
The goal of this clinical trial is to assess the safety and effects of a crystallized form of lithium, AL001, when compared to commonly used lithium carbonate i…
This phase 1 study is designed to evaluate the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of TLC-1180 after single- and multiple-asc…
This is a phase I, randomised, single-blind placebo-controlled, 2-part study to assess the safety, tolerability, pharmacokinetics, pharmacodynamics and food eff…
This study in healthy volunteers aims to compare blood levels and side effects after administration of different formulations of AZD6234. This study will take…
To investigate safety, tolerability, and pharmacokinetics of BI 425809 following single rising doses of BI 425809 in healthy male volunteers; To explore dose pr…